Latest stroke Stories
Saint Luke's becomes third in Missouri and 78th in the nation to be recognized for offering specialized care to patients with the most severe and challenging types of stroke Kansas
Comprehensive Clinical Data from Randomized Trials Reviewed MARLBOROUGH, Mass., Oct.
A new, implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients
As Testosterone Complaints Continue to Increase, the FDA Furthers Its Investigation into Testosterone Use by Holding a Meeting of Its Advisory Panels to Explore the Safety and Effectiveness of
HELSINKI, October 2, 2014 /PRNewswire/ -- Nexstim Oy ("Nexstim" or the "Company"), a medical technology company aiming to improve rehabilitation for stroke patients through
Commercial activities ahead of schedule following release of strong clinical data in the multi-specialty CARENET trial BOSTON, Oct.
Icahn School of Medicine at Mount Sinai research findings show there was no significant difference in 15-year survival or stroke rates in patients aged between 50 and 69 years who had aortic valve
Stroke Survivor will Focus on Building Awareness and Strategic Growth to Expand Organization's 30-Year Legacy CENTENNIAL, Colo., Sept.
LEXINGTON, Ky., Sept.
Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.
More Images (3 images) »